Page last updated: 2024-09-04

lubiprostone and Dyspepsia

lubiprostone has been researched along with Dyspepsia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Talley, NJ	1
Mangel, AW	1

Reviews

1 review(s) available for lubiprostone and Dyspepsia

Article	Year
Green light from the FDA for new drug development in irritable bowel syndrome and functional dyspepsia. The American journal of gastroenterology, 2009, Volume: 104, Issue:6 Topics: Alprostadil; Chloride Channels; Clinical Trials as Topic; Congresses as Topic; Drug Approval; Drug Evaluation; Dyspepsia; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Lubiprostone; United States; United States Food and Drug Administration; Wisconsin	2009

Article

Year

Green light from the FDA for new drug development in irritable bowel syndrome and functional dyspepsia.

The American journal of gastroenterology, 2009, Volume: 104, Issue:6

Topics: Alprostadil; Chloride Channels; Clinical Trials as Topic; Congresses as Topic; Drug Approval; Drug Evaluation; Dyspepsia; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Lubiprostone; United States; United States Food and Drug Administration; Wisconsin

2009

Other Studies

1 other study(ies) available for lubiprostone and Dyspepsia

Article	Year
The FDA and IBS drug development. The American journal of gastroenterology, 2009, Volume: 104, Issue:12 Topics: Alprostadil; Chloride Channels; Clinical Trials as Topic; Congresses as Topic; Drug Approval; Drug Evaluation; Dyspepsia; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Lubiprostone; United States; United States Food and Drug Administration; Wisconsin	2009